Dosing Begins in Trial of PET Imaging Agent to Detect Prostate Cancer’s Return
News
The first patients have been injected in a Phase 3 trial investigating the safety and performance of Blue Earth Diagnostics‘ imaging agent rhPSMA-7.3 (18F) in detecting prostate cancer in men with ... Read more